You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Georgia

May 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Growth after economic crisis

Due to estimations of numerous experts from Georgia, and abroad, 2010 was the last year of the economic crisis.2011 began to show more confident value growth, in comparison with 2010, which although lower was an improvement on 2009’s decline. Calming and sleeping and vitamins and dietary supplements were the top performers in terms of current value growth.

Appearance of private label in Georgian consumer health

In October 2005, pharmaceutical company GPC Ltd implemented a new project of Red A. The aim of the project was to aid independent chemists/pharmacies to retain competitiveness and assist in conducting their business more effectively. By the end of 2011, under the banner of Red A there were almost 100 independent drugstores. From 2011, GPC started placing orders from domestic producers (Batfarma Ltd, Biofarm Georgia) for private label manufacturing under the brand name Red A.

2011 reveals concentration of key brands

2011was marked by a minimal amount of new launches in consumer health. Before the economic crisis, there was practically no category which went without new launches, but in 2011 it was only possible to allocate novelties in analgesics, digestive remedies, medicated skin care, vitamins and dietary supplements and calming and sleeping. Even in the aforementioned categories, new launches were insignificant as well as having little influence on general sales. Manufacturers and distributors preferred to focus their attention on pre-existing and well-known brands and products. Players not only abstained from new launches, but also withdrew the less advertised and promoted brands.

Vending sales start to emerge in Georgia

Changes in legislation regarding the requirements for outlets selling drugs in 2010, allowed the use of vending. The range of vending sales is quite wide and covers almost all categories of consumer health. The number of machines across the country while remaining low is installed in most public places (train stations, supermarkets).In 2010-2011, the culture of using vending was still new, so the main consumers were young people, who are more open to this type of channel.

No significant growth is forecast for consumer health

The constant value performance of consumer health is expected to be considerably stronger during the forecast period than growth witnessed over the review period, when constant value sales declined. However, growth rates are expected to remain moderate for a number of reasons. Despite several favourable changes in consumer health, the situation is far from satisfactory. Key players are not going to yield their positions easily, taking great efforts to do so and it is clear their influence on sales is very strong. Realistically, prices of consumer health remain rather high, the range of products limited, and consumers’ dissatisfaction is high due to low incomes. In other words, it will be very difficult to achieve healthy competition in the short-term.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Georgia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Georgia, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Georgia for free:

The Consumer Health in Georgia market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Georgia?
  • What are the major brands in Georgia?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Georgia - Industry Overview

EXECUTIVE SUMMARY

Growth after economic crisis

Appearance of private label in Georgian consumer health

2011 reveals concentration of key brands

Vending sales start to emerge in Georgia

No significant growth is forecast for consumer health

KEY TRENDS AND DEVELOPMENTS

Increased competition in Georgian consumer health restricts unit price growth

Exchange rate fluctuations affect price growth

Local manufacturers are gaining strength

Sports nutrition emerges in Georgia

Private label enters Georgian consumer health

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

SOURCES

  • Summary 1 Research Sources

Consumer Health in Georgia - Company Profiles

Batfarma Ltd in Consumer Health (Georgia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 4 Batfarma Ltd: Competitive Position 2011

GPC Medical Ltd in Consumer Health (Georgia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

PSP Group in Consumer Health (Georgia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Public Pharmacy Ltd in Consumer Health (Georgia)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Adult Mouth Care in Georgia - Category Analysis

HEADLINES

TRENDS

  • After redistribution of shares in 2009-2010 and the appearance of new player Egis Pharmaceuticals Plc, in 2011 players stabilised their shares. Companies are now concentrating on encouraging sales.

SWITCHES

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline was the leading player in adult mouth care in 2011 with 21% value share, gaining two percentage points derived from its Calgel and Corsodyl brands. These brands benefit from offering a strong global reputation and wide distribution. Unique Pharmaceutical Laboratories ranked second in 2011 with 18% value share, while SopharmaAD ranked third with 15% share. All leader players gained strong value share over the previous year. These brands undercut the unit price of many competitors, with a smaller pack size of 100ml further attracting many price-sensitive consumers, offering a lower initial outlay in comparison to the 300ml packs offered by Sensodyne.

PROSPECTS

  • There will be an increasing focus on oral health over the forecast period. This will be connected to the increased grooming trend in Georgia, but it will also be due to worsening national oral health as a result of unhealthier diets. Dental treatment is very expensive in Georgia. However, as consumers begin to take more of a proactive approach to taking care of their teeth, it is likely to constrain the sales of adult mouth care, as the case of untreated cavities and gum disorders decreases.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2006-2011
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 13 Adult Mouth Care Company Shares 2007-2011
  • Table 14 Adult Mouth Care Brand Shares 2008-2011
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Georgia - Category Analysis

HEADLINES

TRENDS

  • Two major retail pharmacy leaders of Georgia – PSP Group and Aversi-Pharma Ltd constantly expanded their networks of chemists/pharmacies over the review period. These retailers also expand their presence in healthcare, opening new clinics and hospitals. This expansion is expected to greatly benefit their associated manufacturing companies GMP and Aversi-Rational. In its turn, GMP and Aversi-Rational offer a wider range of analgesics and with strong distribution that drove growth of analgesics (as well as other categories of consumer health).

SWITCHES

COMPETITIVE LANDSCAPE

  • The leading player in analgesics is A Menarini Industrie Farmaceutiche Riunite Srl, which held 9% value share in 2011with its Nimesil and Fastum brands. The company benefits from wide distribution via chemists/pharmacies and also from strong advertising support. Due to the company’s presence in the leading chemists/pharmacies chains, it benefited from the ongoing expansion of chains such as Aversi and PSP across the country. A Menarini Industrie Farmaceutiche Riunite Srl notably advertised Fastum Gel strongly via television. Nimesil also benefited from strong advertising support in systemic analgesics. Ranked second place was Bristol-Myers Squibb Co with5% value share in 2011 with its Upsarin and Efferalgan brands. Taking the third position was Lek Pharmaceuticals dd (5% value share in 2011) with popular brand Ketonal.

PROSPECTS

  • More and more research has appeared which questions the efficiency of combination products, and even whether such products can actually be harmful. In analgesics this will lead to slower growth of sales of combination products in favour of popular ketoprofen. Although both types of analgesics are forecasted to show positive performance in the forecast due to consumer interest in this category.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2006-2011
  • Table 18 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 19 Analgesics Company Shares 2007-2011
  • Table 20 Analgesics Brand Shares 2008-2011
  • Table 21 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 22 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Georgia - Category Analysis

HEADLINES

TRENDS

  • In 2011, in calming and sleeping, most major players (Tbilkhimpharm, GM Pharmaceuticals Ltd (GMP), Aversi-Rational Ltd and Aventis SA) managed to significantly increase their value share. They in total control 65% value share of overall sales, which is quite unusual for consumer health in Georgia. Smaller players in this category (Bristol-Myers Squibb Co, Biotiki MNPK OOO, UnipharmInc, Olainfarm AS) in 2011 withdrew, which allowed the leaders to increase their share. In addition, this trend particularly benefited GMP’s Somna Ritz and Aversi-Rational’s Noofen Aversi, due to these producers’ strong links with PSP and Aversi. GMP and Aversi-Rational further capitalised on this opportunity by investing in stronger marketing support for their brands, thus boosting consumer awareness.

SWITCHES

COMPETITIVE LANDSCAPE

  • Tbilkhimpharm was the leading player in calming and sleeping in 2011with 27% value share, gaining two percentage points with its Extract Valeriany and Korvalol brands. Tbilkhimpharm has led calming and sleeping since 2008(both its products are herbal/traditional). It also benefits from frequent recommendations from pharmacists and doctors.

PROSPECTS

  • With active on going urbanisation and improvement of the economic situation in Georgia, calming and sleeping is expected to show a favourable performance. This is connected in particular to increasingly stressful lifestyles, longer working hours and living in more cramped conditions. This will lead to growing interest in calming and sleeping. In addition these products are expected to become widely available through chained chemists/pharmacies.

CATEGORY DATA

  • Table 23 Sales of Calming and Sleeping: Value 2006-2011
  • Table 24 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 25 Calming and Sleeping Company Shares 2007-2011
  • Table 26 Calming and Sleeping Brand Shares 2008-2011
  • Table 27 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 28 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Georgia - Category Analysis

HEADLINES

TRENDS

  • In 2010, cough, cold and allergy (hay fever) remedies in Georgia was led by the brand Salbutamol from Hasco-Lek SA, which provided Hasco-Lek SA with the second position overall in this category. However, in 2011, efforts by the local manufacturer GM Pharmaceuticals Ltd (GMP) to over take Hasco-Lek with its own product Salbutamol succeeded. Salbutamol of the company GMP managed to press heavily on the market Salbutamol of the company Hasco-Lek SA and by the end of 2011 GMP became second on sales in this category. Of course, the fact that GMP has its own extensive network of pharmacies throughout Georgia called PSP Group helped its cause.

SWITCHES

COMPETITIVE LANDSCAPE

  • The leading player in cough, cold and allergy (hay fever) remedies in 2011 was GlaxoSmithKline Plc which held 8% value share. The company offers a wide range of products, including Augmentin, Coldrex, Panadol and Imigran in combination products, Ventolin and Salbutamol in nasal sprays and Actifed in antihistamines/allergy remedies (systemic). The company owes its leading position to its wide range of products and strong marketing support.

PROSPECTS

  • More frequent abnormalities in nature a rapidly changing climate have a negative impact on health and increase the risk of catching colds, that in its turn may raise sales of cough, cold and allergy (hay fever) remedies.

CATEGORY DATA

  • Table 29 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 31 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares 2007-2011
  • Table 32 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares 2008-2011
  • Table 33 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 34 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Georgia - Category Analysis

HEADLINES

TRENDS

  • In Georgia, traditional food is heavy with high fat content, sharp seasonings, and flour products. This, of course, influences the need for digestive remedies – particularly digestive enzymes (Mezym, Panzinorm Forte etc). In the summer season however, the population reduces its consumption of fats and meat and increases consumption of vegetables and fruit, which promotes the sales of antiflatulents (Espumisan).

SWITCHES

COMPETITIVE LANDSCAPE

  • Sanofi-Synthélaboled sales of digestive remedies, accounting for 10% value share in 2011. This player owes its strong position to the popularity of No-spa in IBS treatments. This brand has been present in Georgia for many years and consequently benefits from strong consumer awareness and loyalty. Sanofi-Synthélabo is closely followed by A Menarini with 10% value share, gaining half a percentage point derived from its Mezym digestive enzymes and Espumisan antiflatulents and H2 blockers. Ranked third was Cipla Ltd with its brand Senade. Both company and brand lost two percentage points in value share in 2011, as a a result of more active advertising and promotional activities of the competitors.

PROSPECTS

  • Considering that Georgian consumers do not spend much money on disease prevention, and prefer to buy medicines as a cure when there is no other alternative, the most popular products will remain those that promise fast and effective relief. Manufacturers are therefore likely to focus on promoting these qualities in their brands.

CATEGORY DATA

  • Table 35 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 36 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 37 Digestive Remedies Company Shares 2007-2011
  • Table 38 Digestive Remedies Brand Shares 2008-2011
  • Table 39 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 40 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Georgia - Category Analysis

HEADLINES

TRENDS

  • In 2011, ear care did not witness any changes, with existing players maintaining their positions. Neither external, nor internal environmental issues affected sales significantly. Local manufacturer Aversi-Rational Ltd however managed to erode some share of category leader Sanofi-Aventis, gaining one percentage point to hold 8%.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sanofi-Aventis remained the leading player in ear care in 2011, with its Sofradex brand accounting for 23% value share. This brand has a long history in Georgia and consequently benefits from wide distribution and strong awareness among ear care users. However, Sanofi-Aventis experienced the sharpest decline in value share in 2011, dropping by one percentage point. This was chiefly due to stronger competition from other players, as chemists/pharmacies expanded the range of ear care on offer.

PROSPECTS

  • Lack of investment in ear care will continue to affect sales during the predicted period, with constant value sales expected to remain below GEL1 million in 2016. Players do not wish to invest in new product development or for promotional purposes due to the poor sales trend of ear care. However, constrained sales are due to poor consumer awareness which is difficult to improve, if leaders do not invest in consumer educational activities.

CATEGORY DATA

  • Table 41 Sales of Ear Care: Value 2006-2011
  • Table 42 Sales of Ear Care: % Value Growth 2006-2011
  • Table 43 Ear Care Company Shares 2007-2011
  • Table 44 Ear Care Brand Shares 2008-2011
  • Table 45 Forecast Sales of Ear Care: Value 2011-2016
  • Table 46 Forecast Sales of Ear Care: % Value Growth 2011-2016

Emergency Contraception in Georgia - Category Analysis

HEADLINES

TRENDS

  • Richter Gedeon Nyrt finally became the only player present in 2011 in emergency contraception in Georgia. There is thus little incentive for Richter Gedeon to push for a stronger share through investment in marketing and new product development. There is also little price competition within emergency contraception, with current value sales remaining steady on an annual basis during the review period. In addition, emergency contraception continued to be constrained by cultural considerations. 84% of Georgians are members of the Georgian Orthodox Church, with the majority of the remainder being Muslims. Many Georgians have highly traditional attitudes to unplanned pregnancies and many women would be embarrassed to be seen purchasing emergency contraception. Consequently, those without easy access to reproductive healthcare centres may be too embarrassed to buy emergency contraception.

COMPETITIVE LANDSCAPE

  • Richter Gedeon dominated sales of emergency contraception throughout the review period, rising from 96% value share in 2006 to 100% share in 2011. At the beginning of the review period, other brands accounted for 4-5% value share. However, these players struggled to compete with Richter Gedeon and many exited during the review period. Richter Gedeon has strong distribution links with the leading chains in chemists/pharmacies and its Postinor brand enjoys a strong reputation.

PROSPECTS

  • New players are however expected to enter emergency contraception, as potential of the category is favourable. With growing competition, prices may change also. However for Georgia this category may stay very specific for the long-term, a slow awareness of contraception among young people and some prejudice to protection with the help of pills, have an extremely negative impact on sales of emergency contraception.

CATEGORY DATA

  • Table 47 Sales of Emergency Contraception: Value 2006-2011
  • Table 48 Sales of Emergency Contraception: % Value Growth 2006-2011
  • Table 49 Emergency Contraception Company Shares 2007-2011
  • Table 50 Emergency Contraception Brand Shares 2008-2011
  • Table 51 Forecast Sales of Emergency Contraception: Value 2011-2016
  • Table 52 Forecast Sales of Emergency Contraception: % Value Growth 2011-2016

Eye Care in Georgia - Category Analysis

HEADLINES

TRENDS

  • In general, increased attention toward eye care products, with consumers taking better care of their eyes, is crucial for certain working conditions. Computer usage is expected to increase dramatically, both in terms of frequency and the number of those using computers on a regular basis. This will be partly due to growth in services and urbanisation, with an increasing number of Georgians working in modern offices and using computers. Growth will also be due to a sharp rise in household penetration of personal computers and the internet.

SWITCHES

COMPETITIVE LANDSCAPE

  • Slavyanskaya Apteka was the leading player in eye care in 2011 with a strong 20% value share. This Russian player offers the Levomicetin and Albucid brands in standard eye care and benefits from offering affordable prices. The company increased its exports into Georgia in the last three years of the review period, which resulted in a strong growth in value share.

PROSPECTS

  • The key forecast trend will be increasing share of local manufacturers, spearheaded by GM Pharmaceuticals Ltd (GMP). Gradually, other local players will be interested in entering eye care as well.

CATEGORY DATA

  • Table 53 Sales of Eye Care by Category: Value 2006-2011
  • Table 54 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 55 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 56 Standard Eye Care by Positioning 2007-2011
  • Table 57 Eye Care Company Shares 2007-2011
  • Table 58 Eye Care Brand Shares 2008-2011
  • Table 59 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 60 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Georgia - Category Analysis

HEADLINES

TRENDS

  • In Georgia, herbal/traditional products have traditionally experienced high popularity traditionally. Flora of Georgiais rich with medical herbs, and consumers are very loyal to those products based on familiar herbs. An important role in promoting herbal products is the distribution of mass in formation. The promotion of herbal products is carried out in printed media and programmes devoted to health, so most consumers consider herbal products, as most do not have any side effects.

COMPETITIVE LANDSCAPE

  • The leaders of herbal/traditional products in 2011 were Tbilkhimpharm occupying 12% value share with its brands Valerian and Korvalol, OOO NPF Materia Medica Holding covering 9% share with brands Anaferon, and Cipla Ltd with 8% share with Senade. The main trend on the competitive landscape in 2011 was increasing share of local brands, their promotion and demand revival, for example Valerian gained one percentage point in share.

PROSPECTS

  • The strong tradition of herbal medicine in Georgia is expected to receive growing attention during the forecast period. There is expected to be increasing consumer pride in the strong herbal medicine traditions of Georgia, while these products are also affordable and widely distributed. The consumption of herbal/traditional products is expected to remain strongest among children and the elderly, with these consumers attracted by these products’ gentle effect and lack of side effects. However, it is possible that new consumers may be attracted to herbal/traditional products during the forecast period, particularly if tonics and bottled nutritive drinks or dietary supplements are launched that have a clear positioning. Middle-aged women may for example be attracted by products positioned as maintaining a youthful complexion or assisting in weight loss, while teenagers could be attracted by products claiming to clear acne.

CATEGORY DATA

  • Table 61 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 62 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 63 Herbal/Traditional Products Company Shares 2007-2011
  • Table 64 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 65 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 66 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Georgia - Category Analysis

HEADLINES

TRENDS

  • Consumer awareness is promoted by stronger advertising for many products, both from OTC medicated skin care and from cosmetic skin care players. In addition, the leading chains in chemists/pharmacies, such as Aversi, PSP and Pharmadepot, often conduct consumer education campaigns and offer free consultations, alongside free samples. Consequently, consumers become more confident in their self-medication and buy a wider range of medicated skin care.

SWITCHES

COMPETITIVE LANDSCAPE

  • The leading player in medicated skin care is Nizhpharm OAO, which held 11% value share in 2011. This company offers a wide range of medicated skin care, including Nystatin in vaginal antifungals, Erythromycin and Sintomicin in topical germicidals/antiseptics, Hydrocortisone in antipruritics and Oblepikhovyesuppositorii and Anestesol in haemorrhoid treatments. The company benefits from this wide range and also from its well-trusted brands, which are supported by strong in-store promotion. Ranked second in 2011 was Novartis AG with the brands Lamisil, Fenistil, Venorutonand Vibrocil, and ranked third is Jelfa SA with Flucinar.

PROSPECTS

  • In the short-term, local small businesses, traditionally producing medicated skin care products, will expand their lines of products, in particular at the expense of herbal/traditional products.

CATEGORY DATA

  • Table 67 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 68 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 69 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 70 Medicated Skin Care Brand Shares 2008-2011
  • Table 71 Hair Loss Treatments Brand Shares 2008-2011
  • Table 72 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 73 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

Sports Nutrition in Georgia - Category Analysis

HEADLINES

TRENDS

  • Until 2011, sales of sports nutrition in Georgia were irregular and looked more like a trial. In 2011, the offer remained small with only several brands present, and only in the segments of powder and non-protein products with total value sales comprising GEL80,000.

COMPETITIVE LANDSCAPE

  • Practically, only one company was visible in sports nutrition in Georgian in 2011, which was foreign company Trec Nutrition Sp zoo with brand Trec Nutrition.

PROSPECTS

  • The key forecast trend will be increasing consumer awareness of sport nutrition and thus increasing sales. Gradually, more people will learn about sports nutrition, and there will be new players and increased penetration.

CATEGORY DATA

  • Table 74 Sales of Sports Nutrition: Value 2006-2011
  • Table 75 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 76 Sports Nutrition Company Shares 2007-2011
  • Table 77 Sports Nutrition Brand Shares 2008-2011
  • Table 78 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 79 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Georgia - Category Analysis

HEADLINES

TRENDS

  • In previous years, the trend was to consume particular single purpose vitamins and dietary supplements; however in 2011,the popularity of purchasing complex vitamins prevailed. Consumers began to appreciate and understand the benefit of buying complex vitamins which can be taken in one go rather than spend money on different vitamins separately.

Vitamins

Dietary Supplements

COMPETITIVE LANDSCAPE

  • Krkadd retained its leadership of 2011, and is represented in vitamins and dietary supplements by five brands (Pikovit, Calcinova, Duovit, Bilobil and Triovit) from which only Pikovit occupies 4% share to holdGEL1.7 million in value sales. Krkadd held 10% value share overall in 2011, gaining 1.5 percentage points. Ranked second was Unipharm Inc with 7% value share, with the leading brand Vitrum. Ranked third was Ferrosan A/S, which also gained two percentage points to hold 7% value share with brand Multi-Tabs.

PROSPECTS

  • The importance of leading an active and healthy life style is being increasingly promoted in Georgia. Over the forecast period, consumers are expected to show a growing interest toward health and wellness, yet this may not necessarily benefit vitamins and dietary supplements. A number of consumers still regard fresh fruits, vegetables and herbs as the best source of getting vitamins and nutrients and as there is a wide offer of such products in Georgia, they render serious strong competition to vitamins and dietary supplements. Besides, many people still visit various herbalists to obtain special dietary supplements made for them individually; homemade tonics also remain popular.

CATEGORY DATA

  • Table 80 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 81 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 82 Dietary Supplements by Positioning 2007-2011
  • Table 83 Vitamins and Dietary Supplements Company Shares 2007-2011
  • Table 84 Vitamins and Dietary Supplements Brand Shares 2008-2011
  • Table 85 Vitamins Brand Shares 2008-2011
  • Table 86 Dietary Supplements Brand Shares 2008-2011
  • Table 87 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 88 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016
  • Summary 11 Dietary Supplements: Brand Ranking by Positioning 2011

Weight Management in Georgia - Category Analysis

HEADLINES

TRENDS

  • In 2011, both major local players were particularly active in weight management in Georgia. Ajanta Pharma Ltd almost caught up with sales leader Bional International BV by gaining ten percentage points, and GM Pharmaceuticals Ltd (GMP) increased its share of value sales from 10% to 19%. Both companies began to take much greater efforts to increase advertising and distributing their products Figurin and Orlip, which gave positive results.

COMPETITIVE LANDSCAPE

  • The leading player of weight management in 2011 was Bional International, which held 32% value share with its Apple Slim Extra weight loss supplements. Apple Slim Extra benefits from wide distribution. Bional however lost 20 percentage points in value share in 2011, which was partly due to consumer habits in weight management. Consumers typically try a product for a while before moving on to see if they have more success with another product. In addition, consumers are easily attracted to new launches. Bional saw sales decline in 2011, while Ajanta’s Figurin and GMP’s Orlip (following its launch of Apple Slim Extra in 2008) both essentially boosted sales in 2011. Figurin notably accounting for 30% value share in 2011 and Orlip – 20%. Similarly, Apple Slim Extra suffered due to the launch of Guno Water in 2009.In 2011,both major local players were active in weight management in Georgia. Ajanta Pharma Ltd almost caught up on sales leader Bional International BV, and GM Pharmaceuticals Ltd (GMP) increased its share of value sales from 10% to 19%. Both companies began to take much greater efforts to increase advertising and distributing their products Figurin and Orlip, which gave positive results.

PROSPECTS

  • Due to changing lifestyles in Georgia is expected to reveal an even sharper rise in weight problems over the forecast period. Economic growth and on going urbanisation in Georgia is expected to lead to increasing sedentary lifestyles. In addition, fast food networks and supermarkets/hypermarkets will be more widespread across the country, making consumers increasingly reliant on processed food and consumer foodservice. Despite this, most consumers will continue to equate slimness with beauty, especially among women, thus revealing growing interest and demand toward weight control methods.

CATEGORY DATA

  • Table 89 Sales of Weight Management by Category: Value 2006-2011
  • Table 90 Sales of Weight Management by Category: % Value Growth 2006-2011
  • Table 91 Weight Management Company Shares 2007-2011
  • Table 92 Weight Management Brand Shares 2008-2011
  • Table 93 Forecast Sales of Weight Management by Category: Value 2011-2016
  • Table 94 Forecast Sales of Weight Management by Category: % Value Growth 2011-2016

Wound Care in Georgia - Category Analysis

HEADLINES

TRENDS

  • In 2011, consumption of products designed for increasingly specific purposes, particular consumer niches, more sophisticated segmentation (such as targeting sports enthusiasts) grew. Wound care is a traditional, well-mastered category by the consumer. Manufacturers are trying to offer something new to fill different niches in order to intensify sales, which customers appreciate.

COMPETITIVE LANDSCAPE

  • Betasan AS was the leading player in wound care in 2011, holding 31% value share with its Santavik and Betasan brands. This Turkish player benefits from offering affordable prices and also from offering a wide range of pack sizes, ranging from 10 to 100 units. It also benefits from offering innovative products containing natural extracts, such as capsicum and zinc oxide to assist in healing and relieve pain. Betasan also has the widest distribution within wound care. Ranked second was the higher-priced multinational Johnson& Johnson Inc with 10% value share, with local company Bamba Ltd (10% value share) ranked third. This company is the leading player in gauze, tape and other wound care and offers a wide range. The company consequently benefited most from chemists/pharmacies expanding their range of products in this area.

PROSPECTS

  • Wound care is expected to see a favourable performance over the forecast period, as Georgia gradually recovers from the economic crisis and living conditions improve. As consumers’ disposable income levels increase, consumers are likely to trade up to specialised and specific products. In addition, wound care for specific body parts, for example hands or feet, is likely to gain share, as will products designed for specific consumer groups such as sports enthusiasts. Products with additional functional ingredients, such as capsicum and zinc oxide sticking plasters/adhesive bandages are expected to gain share. Leading players in wound care are expected to respond to this trend by launching new packaging designs. Meanwhile, spray-on sticking plasters/adhesive bandages are likely to become significant during the forecast period.

CATEGORY DATA

  • Table 95 Sales of Wound Care by Category: Value 2006-2011
  • Table 96 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 97 Wound Care Company Shares 2007-2011
  • Table 98 Wound Care Brand Shares 2008-2011
  • Table 99 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 100 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Paediatric Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Paediatric Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Paediatric Consumer Health
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
          • Paediatric Cough, Cold and Allergy Remedies
            • Paediatric Allergy Remedies
            • Paediatric Cough/Cold Remedies
          • Paediatric Digestive Remedies
            • Paediatric Diarrhoeal Remedies
            • Paediatric Indigestion and Heartburn Remedies
            • Paediatric Laxatives
            • Paediatric Motion Sickness Remedies
          • Paediatric Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Paediatric Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market sizes
      • Company shares
      • Brand shares
      • Distribution
      • Analysis by format
      • Analysis by positioning
      • Herbal/traditional vs standard
      • Pricing
      • Smoking population - number of adult smokers
      • Smoking prevalence - % of adult population

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!